We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMHC
476
DELISTED
Taylor Morrison
TMHC
| $3.3M | 0.02% |
+124,810
| New | +$3.71M |
|
477
Ross Stores
ROST
$81.4B
| $3.29M | 0.02% |
21,972
+907
| +4% | +$113K |
|
478
Ametek
AME
$54.2B
| $3.27M | 0.02% |
24,462
+1,619
| +7% | +$217K |
|
479
Fortive
FTV
$18B
| $3.25M | 0.02% |
61,854
+11,862
| +24% | +$639K |
|
480
Lennox International
LII
$15.2B
| $3.23M | 0.02% |
+9,218
| New | +$3.11M |
|
481
Consolidated Edison
ED
$41.3B
| $3.22M | 0.02% |
44,906
-9,402
| -17% | -$722K |
|
482
Hain Celestial
HAIN
$45.9M
| $3.21M | 0.02% |
+80,083
| New | +$3.31M |
|
|
SYRS
483
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.18M | 0.02% |
+58,427
| New | +$3.46M |
|
|
BCEL
484
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $3.18M | 0.02% |
373,706
+373,681
| +1,494,724% | +$3.83M |
|
485
Edison International
EIX
$30.5B
| $3.18M | 0.02% |
54,966
+15,998
| +41% | +$931K |
|
486
Aflac
AFL
$65.8B
| $3.18M | 0.02% |
59,205
-18,056
| -23% | -$985K |
|
487
Eversource Energy
ES
$28.2B
| $3.17M | 0.02% |
39,518
-23,821
| -38% | -$2.01M |
|
488
Nomad Foods
NOMD
$1.76B
| $3.17M | 0.02% |
112,044
+26,185
| +30% | +$771K |
|
|
TWTR
489
DELISTED
Twitter, Inc.
TWTR
| $3.16M | 0.02% |
45,873
-158,132
| -78% | -$9.69M |
|
490
Workday
WDAY
$41.7B
| $3.15M | 0.02% |
13,177
-26,295
| -67% | -$6.32M |
|
|
AKRO
491
DELISTED
Akero Therapeutics
AKRO
| $3.14M | 0.02% |
126,667
+30,269
| +31% | +$850K |
|
492
Monster Beverage
MNST
$95.3B
| $3.14M | 0.02% |
68,686
-121,250
| -64% | -$5.69M |
|
|
SNBR
493
DELISTED
Sleep Number
SNBR
| $3.12M | 0.02% |
28,360
+12,853
| +83% | +$1.46M |
|
494
Valmont Industries
VMI
$8.91B
| $3.11M | 0.02% |
+13,174
| New | +$3.19M |
|
495
Emcor
EME
$30.2B
| $3.11M | 0.02% |
+25,238
| New | +$3.08M |
|
496
Kodiak Sciences
KOD
$2.48B
| $3.09M | 0.02% |
33,186
-112,483
| -77% | -$10.8M |
|
497
CGI
GIB
$15.6B
| $3.08M | 0.02% |
33,879
+27,872
| +464% | +$2.47M |
|
498
Constellation Brands
STZ
$22.5B
| $3.06M | 0.02% |
13,100
-18,209
| -58% | -$4.27M |
|
499
Global Payments
GPN
$24.1B
| $3.03M | 0.02% |
16,143
+164
| +1% | +$33K |
|
|
DFS
500
DELISTED
Discover Financial Services
DFS
| $2.97M | 0.02% |
25,130
-1,743
| -6% | -$197K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.